Ignite Creation Date:
2024-05-06 @ 3:16 PM
Last Modification Date:
2024-10-26 @ 1:46 PM
Study NCT ID:
NCT04577612
Status:
COMPLETED
Last Update Posted:
2021-06-03
First Post:
2020-09-30
Brief Title:
A Randomized Controlled Test of the Effects of CHI-554 on Fear
Sponsor:
Canopy Growth Corporation
Organization:
Canopy Growth Corporation
Study Overview
Official Title:
A Randomized Controlled Test of the Effects of CHI-554 on Fear F-01
Status:
COMPLETED
Status Verified Date:
2021-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized double-blind placebo-controlled phase 2b clinical trial examining the effects of CHI-554 CBD on Fear F-01
Detailed Description:
This study will examine the potential of a novel formulation of hemp-derived CBD CHI-554 to reduce fear elicited via a safe well-established controlled laboratory-based carbon dioxide CO2-enriched air biological challenge that causes abrupt increases in bodily arousal
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None